Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 22

Sort by

Sort Order Select

Meeting Abstracts

174-OR: Genetic Variation in GLP-1R Modify the Risk of Hypoglycemia in Response to Intensive Glycemic Control in Adults with Type 2 Diabetes

QIAOCHU XUE, PIAOPIAO LI, RAM JAGANNATHAN, FRANCISCO J. PASQUEL, GUILLERMO UMPIERREZ, LAWRENCE S. PHILLIPS, MOHAMMED K. ALI, HUI SHAO

Diabetes 2024;73(Supplement_1):174-OR

https://doi.org/10.2337/db24-174-OR

Published: 14 June 2024

View articletitled, 174-OR: Genetic Variation in GLP-1R Modify the Risk of Hypoglycemia in Response to Intensive Glycemic Control in Adults with Type 2 Diabetes

Meeting Abstracts

1027-P: Assessment of Glycemic Control by CGM during Hospitalization and Post-discharge in Insulin-Treated Older Adults

THAER IDREES, SRIYA KANTIPUDI, ZOHYRA ZABALA, BOBAK MOAZZAMI, MARIA A. URRUTIA, SIYU ZHOU, PRIYATHAMA VELLANKI, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2024;73(Supplement_1):1027-P

https://doi.org/10.2337/db24-1027-P

Published: 14 June 2024

View articletitled, 1027-P: Assessment of Glycemic Control by CGM during Hospitalization and Post-discharge in Insulin-Treated Older Adults

Meeting Abstracts

1710-P: Weight Stigma and Discrimination among Hispanics and Non-Hispanic Whites and Blacks with Obesity and Diabetes in the U.S.

RODOLFO J. GALINDO, ZOHYRA ZABALA, GIULIANA AREVALO, BOBAK MOAZZAMI, ALBERT LECUBE, AMMAR A. RASHIED, GUILLERMO UMPIERREZ

Diabetes 2024;73(Supplement_1):1710-P

https://doi.org/10.2337/db24-1710-P

Published: 14 June 2024

View articletitled, 1710-P: Weight Stigma and Discrimination among Hispanics and Non-Hispanic Whites and Blacks with Obesity and Diabetes in the U.S.

Meeting Abstracts

413-P: Comparative Effectiveness of Glucose-Lowering Agents on Kidney Outcomes in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk

JOSHUA J. NEUMILLER, JEPH HERRIN, KAVYA SWARNA, ERIC POLLEY, RODOLFO J. GALINDO, GUILLERMO UMPIERREZ, YIHONG DENG, MINDY MICKELSON, ROZALINA G. MCCOY

Diabetes 2024;73(Supplement_1):413-P

https://doi.org/10.2337/db24-413-P

Published: 14 June 2024

View articletitled, 413-P: Comparative Effectiveness of Glucose-Lowering Agents on Kidney Outcomes in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk

Meeting Abstracts

1047-P: Estimating QALY-Based Price Ranges for Diabetes Drugs under IRA Negotiation

PIAOPIAO LI, JIEUN LEE, XIN HU, K M VENKAT NARAYAN, GUILLERMO UMPIERREZ, LIZHENG SHI, VIVIAN FONSECA, MOHAMMED K. ALI, HUI SHAO

Diabetes 2024;73(Supplement_1):1047-P

https://doi.org/10.2337/db24-1047-P

Published: 14 June 2024

View articletitled, 1047-P: Estimating QALY-Based Price Ranges for Diabetes Drugs under IRA Negotiation

Meeting Abstracts

36-OR: Modulation of Cardiorenal Benefits for GLP-1RAs Treatment by GLP1R Genetic Variants

QIAOCHU XUE, PIAOPIAO LI, FRANCISCO J. PASQUEL, LAWRENCE S. PHILLIPS, DONGHAI LIANG, K M VENKAT NARAYAN, GUILLERMO UMPIERREZ, MOHAMMED K. ALI, HUI SHAO

Diabetes 2024;73(Supplement_1):36-OR

https://doi.org/10.2337/db24-36-OR

Published: 14 June 2024

View articletitled, 36-OR: Modulation of Cardiorenal Benefits for GLP-1RAs Treatment by GLP1R Genetic Variants

Meeting Abstracts

1023-P: Predictive Value of Admission Plasma Glucose and Hemoglobin A1c on Inpatient Glycemic Control Assessed by Continuous Glucose Monitoring (CGM) in Medicine and Surgery Persons with Diabetes

IRIS A. CASTRO-REVOREDO, SIYU ZHOU, MARIA A. URRUTIA, PRIYATHAMA VELLANKI, THAER IDREES, ZOHYRA ZABALA, RODOLFO J. GALINDO, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2024;73(Supplement_1):1023-P

https://doi.org/10.2337/db24-1023-P

Published: 14 June 2024

View articletitled, 1023-P: Predictive Value of Admission Plasma Glucose and Hemoglobin A1c on Inpatient Glycemic Control Assessed by Continuous Glucose Monitoring (CGM) in Medicine and Surgery Persons with Diabetes

Meeting Abstracts

829-P: iGlarLixi vs. Basal-Bolus (BB) or Premixed Insulin in Older Adult Ethnic Minorities with Type 2 Diabetes (T2D)

GUILLERMO UMPIERREZ, JASVINDER GILL, DAVID HOOD, XUAN LI, ANA NÚÑEZ

Diabetes 2024;73(Supplement_1):829-P

https://doi.org/10.2337/db24-829-P

Published: 14 June 2024

View articletitled, 829-P: iGlarLixi vs. Basal-Bolus (BB) or Premixed Insulin in Older Adult Ethnic Minorities with Type 2 Diabetes (T2D)

Meeting Abstracts

961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis

RODOLFO J. GALINDO, AMANY Y.G. GERGES, BOBAK MOAZZAMI, LIMIN PENG, KATHERINE R. TUTTLE, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):961-P

https://doi.org/10.2337/db23-961-P

Published: 20 June 2023

View articletitled, 961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis

Meeting Abstracts

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM)

RODOLFO J. GALINDO, BOBAK MOAZZAMI, AMANY Y.G. GERGES, LIMIN PENG, KATHERINE R. TUTTLE, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):960-P

https://doi.org/10.2337/db23-960-P

Published: 20 June 2023

View articletitled, 960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM)

Meeting Abstracts

957-P: Continuous Glucose Monitoring in Patients with End-Stage Kidney Disease and Burnt-Out Diabetes

CANDICE KAMINSKI, RODOLFO J. GALINDO, ZOHYRA E. ZABALA, BOBAK MOAZZAMI, AMANY Y.G. GERGES, ROZALINA G. MCCOY, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):957-P

https://doi.org/10.2337/db23-957-P

Published: 20 June 2023

View articletitled, 957-P: Continuous Glucose Monitoring in Patients with End-Stage Kidney Disease and Burnt-Out Diabetes

Meeting Abstracts

859-P: Study of Oral Antihyperglycemic Agents in the Hospital—A Multinational Perspective

MAYA FAYFMAN, IRIT HOCHBERG, MICHELLE F. MAGEE, AMMAR A. RASHIED, RAM JAGANNATHAN, GERARDO BLANCO, EMMELIN MARIE MORENO, FRANCISCO J. PASQUEL, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):859-P

https://doi.org/10.2337/db23-859-P

Published: 20 June 2023

View articletitled, 859-P: Study of Oral Antihyperglycemic Agents in the Hospital—A Multinational Perspective

Meeting Abstracts

1022-P: Trends in Glucagon Fill Rates among U.S. Adults with Diabetes and End-Stage Kidney Disease on Dialysis

RODOLFO J. GALINDO, SHEALEIGH INSELMAN, BOBAK MOAZZAMI, MOHAMMED K. ALI, GUILLERMO UMPIERREZ, ROZALINA G. MCCOY

Diabetes 2023;72(Supplement_1):1022-P

https://doi.org/10.2337/db23-1022-P

Published: 20 June 2023

View articletitled, 1022-P: Trends in Glucagon Fill Rates among U.S. Adults with Diabetes and End-Stage Kidney Disease on Dialysis

Meeting Abstracts

947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

THAER IDREES, IRIS A. CASTRO-REVOREDO, MONICA D. GAVALLER, HYUNGSEOK OH, ZOHYRA ZABALA, EMMELIN M. MORENO, BOBAK MOAZZAMI, RODOLFO J. GALINDO, ELENA CABB, THEODORE M. JOHNSON, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):947-P

https://doi.org/10.2337/db23-947-P

Published: 20 June 2023

View articletitled, 947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

Meeting Abstracts

829-P: Outcomes with Finerenone in People with CKD and T2D by Baseline Insulin Resistance—A FIDELITY Subgroup Analysis

THOMAS EBERT, STEFAN ANKER, LUIS M. RUILOPE, PAOLA FIORETTO, VIVIAN FONSECA, GUILLERMO UMPIERREZ, ANDREAS L. BIRKENFELD, ROBERT LAWATSCHECK, CHARLIE SCOTT, KATJA ROHWEDDER, PETER ROSSING

Diabetes 2023;72(Supplement_1):829-P

https://doi.org/10.2337/db23-829-P

Published: 20 June 2023

View articletitled, 829-P: Outcomes with Finerenone in People with CKD and T2D by Baseline Insulin Resistance—A FIDELITY Subgroup Analysis

Meeting Abstracts

498-P: Prevalence and Impact on Quality of Life of Diabetic Retinopathy in African Americans with End-Stage Kidney Disease on Hemodialysis

ZOHYRA E. ZABALA, BOBAK MOAZZAMI, MICHELLE EGEOLU, RAMONCITO L. CALEON, AMANY Y.G. GERGES, RODOLFO J. GALINDO, ROZALINA G. MCCOY, LIMIN PENG, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):498-P

https://doi.org/10.2337/db23-498-P

Published: 20 June 2023

View articletitled, 498-P: Prevalence and Impact on Quality of Life of Diabetic Retinopathy in African Americans with End-Stage Kidney Disease on Hemodialysis

Meeting Abstracts

1234-P: Derivation of a Claims-Computable Major Adverse Cardiovascular Event Estimator (ACME) in Adults with Type 2 Diabetes

ROZALINA G. MCCOY, KAVYA SWARNA, YIHONG DENG, JEPH HERRIN, JOSEPH ROSS, DAVID M. KENT, BIJAN BORAH, WILLIAM CROWN, VICTOR M. MONTORI, GUILLERMO UMPIERREZ, RODOLFO J. GALINDO, JUAN BRITO, MINDY MICKELSON, ERIC POLLEY

Diabetes 2023;72(Supplement_1):1234-P

https://doi.org/10.2337/db23-1234-P

Published: 20 June 2023

View articletitled, 1234-P: Derivation of a Claims-Computable Major Adverse Cardiovascular Event Estimator (ACME) in Adults with Type 2 Diabetes

Meeting Abstracts

1006-P: Distributional Cost-Effectiveness Analysis of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) and Tirzepatide Compared with Sulfonylureas (SU) in People with Inadequately Controlled Type 2 Diabetes (T2D)

PIAOPIAO LI, DAWEI GUAN, MOHAMMED K. ALI, K.M. VENKAT NARAYAN, VIVIAN FONSECA, GUILLERMO UMPIERREZ, LIZHENG SHI, JIANG BIAN, YI GUO, ALMUT G. WINTERSTEIN, JINGCHUAN GUO, HUI SHAO

Diabetes 2023;72(Supplement_1):1006-P

https://doi.org/10.2337/db23-1006-P

Published: 20 June 2023

View articletitled, 1006-P: Distributional Cost-Effectiveness Analysis of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) and Tirzepatide Compared with Sulfonylureas (SU) in People with Inadequately Controlled Type 2 Diabetes (T2D)

Meeting Abstracts

647-P: Patient Preferences Informing Choice of Second-Line Type 2 Diabetes Medications

ELIZABETH GOLEMBIEWSKI, ANDREA E. GARCIA, ERIC POLLEY, GUILLERMO UMPIERREZ, RODOLFO J. GALINDO, JUAN BRITO, VICTOR M. MONTORI, MINDY MICKELSON, ROZALINA G. MCCOY

Diabetes 2023;72(Supplement_1):647-P

https://doi.org/10.2337/db23-647-P

Published: 20 June 2023

View articletitled, 647-P: Patient Preferences Informing Choice of Second-Line Type 2 Diabetes Medications

Meeting Abstracts

812-P: Tight vs. Standard Inpatient Glycemic Targets in Non–Critical Care Settings—A Propensity Scored–Matched Analysis of Insulin-Treated Patients with Type 2 Diabetes

JARROD SALING, ALEXANDRA L. MIGDAL, MARIA A. URRUTIA, ZOHYRA ZABALA, BOBAK MOAZZAMI, RODOLFO J. GALINDO, MAYA FAYFMAN, AMMAR A. RASHIED, GUILLERMO UMPIERREZ

Diabetes 2023;72(Supplement_1):812-P

https://doi.org/10.2337/db23-812-P

Published: 20 June 2023

View articletitled, 812-P: Tight vs. Standard Inpatient Glycemic Targets in Non–Critical Care Settings—A Propensity Scored–Matched Analysis of Insulin-Treated Patients with Type 2 Diabetes

Update search

NARROW

Format

Journal

Article Type

Topics

Issue Section

Date

Availability

174-OR: Genetic Variation in GLP-1R Modify the Risk of Hypoglycemia in Response to Intensive Glycemic Control in Adults with Type 2 Diabetes

1027-P: Assessment of Glycemic Control by CGM during Hospitalization and Post-discharge in Insulin-Treated Older Adults

1710-P: Weight Stigma and Discrimination among Hispanics and Non-Hispanic Whites and Blacks with Obesity and Diabetes in the U.S.

413-P: Comparative Effectiveness of Glucose-Lowering Agents on Kidney Outcomes in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk

1047-P: Estimating QALY-Based Price Ranges for Diabetes Drugs under IRA Negotiation

36-OR: Modulation of Cardiorenal Benefits for GLP-1RAs Treatment by GLP1R Genetic Variants

1023-P: Predictive Value of Admission Plasma Glucose and Hemoglobin A1c on Inpatient Glycemic Control Assessed by Continuous Glucose Monitoring (CGM) in Medicine and Surgery Persons with Diabetes

829-P: iGlarLixi vs. Basal-Bolus (BB) or Premixed Insulin in Older Adult Ethnic Minorities with Type 2 Diabetes (T2D)

961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis

960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM)

957-P: Continuous Glucose Monitoring in Patients with End-Stage Kidney Disease and Burnt-Out Diabetes

859-P: Study of Oral Antihyperglycemic Agents in the Hospital—A Multinational Perspective

1022-P: Trends in Glucagon Fill Rates among U.S. Adults with Diabetes and End-Stage Kidney Disease on Dialysis

947-P: Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities

829-P: Outcomes with Finerenone in People with CKD and T2D by Baseline Insulin Resistance—A FIDELITY Subgroup Analysis

498-P: Prevalence and Impact on Quality of Life of Diabetic Retinopathy in African Americans with End-Stage Kidney Disease on Hemodialysis

1234-P: Derivation of a Claims-Computable Major Adverse Cardiovascular Event Estimator (ACME) in Adults with Type 2 Diabetes

1006-P: Distributional Cost-Effectiveness Analysis of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) and Tirzepatide Compared with Sulfonylureas (SU) in People with Inadequately Controlled Type 2 Diabetes (T2D)

647-P: Patient Preferences Informing Choice of Second-Line Type 2 Diabetes Medications

812-P: Tight vs. Standard Inpatient Glycemic Targets in Non–Critical Care Settings—A Propensity Scored–Matched Analysis of Insulin-Treated Patients with Type 2 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only